,NU 636 Quiz 2 Advanced Pharmacology |
Herzing University | 26/27 Actual (PDF)
1. Which statement accurately describes the mechanism by which ACE inhibitors reduce blood
pressure?
A) Blocking angiotensin II receptors on vascular smooth muscle
B) Inhibiting the conversion of angiotensin I to angiotensin II
C) Preventing calcium influx into cardiac myocytes
D) Antagonizing beta-adrenergic receptors in the heart
Correct Answer: Inhibiting the conversion of angiotensin I to angiotensin II
Rationale: ACE inhibitors block the angiotensin-converting enzyme, preventing conversion of
angiotensin I to the potent vasoconstrictor angiotensin II. ARBs block the receptor directly rather than
inhibiting conversion. Calcium channel blockers and beta-blockers act through entirely different
mechanisms unrelated to the renin-angiotensin system.
2. A 55-year-old African American male with stage 2 hypertension requires initial pharmacotherapy.
According to JNC 8 guidelines, which agent is preferred as first-line therapy for this patient?
A) Beta-blocker
B) ACE inhibitor
C) Thiazide diuretic
D) Alpha-blocker
Correct Answer: Thiazide diuretic
Rationale: JNC 8 guidelines recommend thiazide diuretics or calcium channel blockers as preferred
initial therapy for African American patients without chronic kidney disease. ACE inhibitors are less
effective as monotherapy in this population due to lower plasma renin activity. Beta-blockers and
alpha-blockers are not recommended as first-line agents.
,3. What is the primary mechanism by which statins lower LDL cholesterol levels?
A) Inhibiting intestinal cholesterol absorption
B) Inhibiting HMG-CoA reductase and upregulating LDL receptors
C) Increasing bile acid excretion through sequestration
D) Activating lipoprotein lipase to enhance triglyceride clearance
Correct Answer: Inhibiting HMG-CoA reductase and upregulating LDL receptors
Rationale: Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol
synthesis, leading to decreased intracellular cholesterol and compensatory upregulation of hepatic
LDL receptors. Ezetimibe inhibits intestinal absorption. Bile acid sequestrants increase bile acid
excretion. Fibrates activate lipoprotein lipase.
4. Which adverse effect is most characteristic of statin therapy and warrants immediate clinical
evaluation?
A) Dry cough
B) Peripheral edema
C) Myopathy with elevated creatine kinase
D) Bradycardia
Correct Answer: Myopathy with elevated creatine kinase
Rationale: Statin-associated myopathy ranges from myalgia to rhabdomyolysis and is the most
characteristic serious adverse effect. Creatine kinase elevation suggests muscle injury requiring
prompt evaluation. Dry cough is associated with ACE inhibitors. Peripheral edema is typical of calcium
channel blockers. Bradycardia is associated with beta-blockers.
5. A patient with heart failure and reduced ejection fraction is initiated on carvedilol. Which
statement best explains the therapeutic rationale for this medication?
A) It increases cardiac contractility through beta-1 agonism
B) It reduces mortality by blocking beta-adrenergic and alpha-adrenergic receptors
C) It eliminates excess fluid through potent diuretic action
, D) It directly inhibits the renin-angiotensin-aldosterone system
Correct Answer: It reduces mortality by blocking beta-adrenergic and alpha-adrenergic receptors
Rationale: Carvedilol is a nonselective beta-blocker with alpha-1 blocking properties that reduces
mortality in heart failure by decreasing cardiac workload and preventing adverse remodeling. It does
not increase contractility. Loop diuretics manage fluid overload. ACE inhibitors and ARBs directly
inhibit the renin-angiotensin-aldosterone system.
6. Which laboratory parameter is essential to monitor in a patient receiving digoxin therapy for heart
failure?
A) Serum amylase
B) Serum digoxin level
C) Serum calcium
D) Serum magnesium
Correct Answer: Serum digoxin level
Rationale: Digoxin has a narrow therapeutic index of 0.5 to 2.0 ng/mL, requiring routine serum level
monitoring to prevent toxicity. Amylase, calcium, and magnesium are not primary monitoring
parameters for digoxin therapy. Potassium levels should also be monitored because hypokalemia
increases toxicity risk.
7. A patient on atorvastatin reports bilateral lower extremity muscle pain and weakness. Which
laboratory test is most important to obtain?
A) Serum creatinine
B) Creatine kinase
C) Liver function tests
D) Complete blood count
Correct Answer: Creatine kinase
Herzing University | 26/27 Actual (PDF)
1. Which statement accurately describes the mechanism by which ACE inhibitors reduce blood
pressure?
A) Blocking angiotensin II receptors on vascular smooth muscle
B) Inhibiting the conversion of angiotensin I to angiotensin II
C) Preventing calcium influx into cardiac myocytes
D) Antagonizing beta-adrenergic receptors in the heart
Correct Answer: Inhibiting the conversion of angiotensin I to angiotensin II
Rationale: ACE inhibitors block the angiotensin-converting enzyme, preventing conversion of
angiotensin I to the potent vasoconstrictor angiotensin II. ARBs block the receptor directly rather than
inhibiting conversion. Calcium channel blockers and beta-blockers act through entirely different
mechanisms unrelated to the renin-angiotensin system.
2. A 55-year-old African American male with stage 2 hypertension requires initial pharmacotherapy.
According to JNC 8 guidelines, which agent is preferred as first-line therapy for this patient?
A) Beta-blocker
B) ACE inhibitor
C) Thiazide diuretic
D) Alpha-blocker
Correct Answer: Thiazide diuretic
Rationale: JNC 8 guidelines recommend thiazide diuretics or calcium channel blockers as preferred
initial therapy for African American patients without chronic kidney disease. ACE inhibitors are less
effective as monotherapy in this population due to lower plasma renin activity. Beta-blockers and
alpha-blockers are not recommended as first-line agents.
,3. What is the primary mechanism by which statins lower LDL cholesterol levels?
A) Inhibiting intestinal cholesterol absorption
B) Inhibiting HMG-CoA reductase and upregulating LDL receptors
C) Increasing bile acid excretion through sequestration
D) Activating lipoprotein lipase to enhance triglyceride clearance
Correct Answer: Inhibiting HMG-CoA reductase and upregulating LDL receptors
Rationale: Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol
synthesis, leading to decreased intracellular cholesterol and compensatory upregulation of hepatic
LDL receptors. Ezetimibe inhibits intestinal absorption. Bile acid sequestrants increase bile acid
excretion. Fibrates activate lipoprotein lipase.
4. Which adverse effect is most characteristic of statin therapy and warrants immediate clinical
evaluation?
A) Dry cough
B) Peripheral edema
C) Myopathy with elevated creatine kinase
D) Bradycardia
Correct Answer: Myopathy with elevated creatine kinase
Rationale: Statin-associated myopathy ranges from myalgia to rhabdomyolysis and is the most
characteristic serious adverse effect. Creatine kinase elevation suggests muscle injury requiring
prompt evaluation. Dry cough is associated with ACE inhibitors. Peripheral edema is typical of calcium
channel blockers. Bradycardia is associated with beta-blockers.
5. A patient with heart failure and reduced ejection fraction is initiated on carvedilol. Which
statement best explains the therapeutic rationale for this medication?
A) It increases cardiac contractility through beta-1 agonism
B) It reduces mortality by blocking beta-adrenergic and alpha-adrenergic receptors
C) It eliminates excess fluid through potent diuretic action
, D) It directly inhibits the renin-angiotensin-aldosterone system
Correct Answer: It reduces mortality by blocking beta-adrenergic and alpha-adrenergic receptors
Rationale: Carvedilol is a nonselective beta-blocker with alpha-1 blocking properties that reduces
mortality in heart failure by decreasing cardiac workload and preventing adverse remodeling. It does
not increase contractility. Loop diuretics manage fluid overload. ACE inhibitors and ARBs directly
inhibit the renin-angiotensin-aldosterone system.
6. Which laboratory parameter is essential to monitor in a patient receiving digoxin therapy for heart
failure?
A) Serum amylase
B) Serum digoxin level
C) Serum calcium
D) Serum magnesium
Correct Answer: Serum digoxin level
Rationale: Digoxin has a narrow therapeutic index of 0.5 to 2.0 ng/mL, requiring routine serum level
monitoring to prevent toxicity. Amylase, calcium, and magnesium are not primary monitoring
parameters for digoxin therapy. Potassium levels should also be monitored because hypokalemia
increases toxicity risk.
7. A patient on atorvastatin reports bilateral lower extremity muscle pain and weakness. Which
laboratory test is most important to obtain?
A) Serum creatinine
B) Creatine kinase
C) Liver function tests
D) Complete blood count
Correct Answer: Creatine kinase
